TriangleFasting Mimicking Diet (FMD) (NCT05832086)
Fasting Mimicking Diet (FMD) trial for Prostate Adenocarcinoma (NCT05832086). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for men with metastatic, hormone-sensitive prostate adenocarcinoma receiving or starting first-line intensified hormone treatment within thirty days of registration. English or Spanish and telephone access are required.
The idea: all patients continue standard cancer care. One group follows a fasting-mimicking diet for five days monthly over six months; the other receives usual diet and exercise guidance. Dietitians supervise the study. Researchers compare PSA responses and metabolic outcomes, rather than assuming fasting improves cancer control.
This phase 2 study plans 138 patients. Stephen Freedland sponsors it; three US sites recruit.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.